Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

614 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons.
Yoshioka N, Tokuda T, Koyama A, Yamada T, Nishikawa R, Shimamura K, Takagi K, Morita Y, Tanaka A, Ishii H, Morishima I, Murohara T; on the ASIGARU PAD investigators. Yoshioka N, et al. Among authors: nishikawa r. Heart Vessels. 2022 Apr;37(4):555-566. doi: 10.1007/s00380-021-01941-9. Epub 2021 Sep 22. Heart Vessels. 2022. PMID: 34553242
Correction to: Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons.
Yoshioka N, Tokuda T, Koyama A, Yamada T, Nishikawa R, Shimamura K, Takagi K, Morita Y, Tanaka A, Ishii H, Morishima I, Murohara T; on the ASIGARU PAD investigators. Yoshioka N, et al. Among authors: nishikawa r. Heart Vessels. 2022 Apr;37(4):567. doi: 10.1007/s00380-021-01962-4. Heart Vessels. 2022. PMID: 34668032 No abstract available.
Two-year clinical outcomes and predictors of restenosis following the use of polymer-coated paclitaxel-eluting stents or drug-coated balloons in patients with femoropopliteal artery disease.
Yoshioka N, Tokuda T, Koyama A, Yamada T, Shimamura K, Nishikawa R, Morita Y, Morishima I; ASIGARU PAD investigators. Yoshioka N, et al. Among authors: nishikawa r. Heart Vessels. 2023 Mar;38(3):429-437. doi: 10.1007/s00380-022-02182-0. Epub 2022 Sep 28. Heart Vessels. 2023. PMID: 36169709
Validation of the Usefulness of the Diameter Reduction, Spiral Shape, Flow Impairment, or Adverse Morphology Classification System in Real-World Clinical Practice.
Yamada T, Tokuda T, Yoshioka N, Koyama A, Nishikawa R, Shimamura K, Tsuruoka T, Mitsuoka H, Aoyama T. Yamada T, et al. Among authors: nishikawa r. J Atheroscler Thromb. 2024 Feb 1;31(2):148-157. doi: 10.5551/jat.64335. Epub 2023 Aug 9. J Atheroscler Thromb. 2024. PMID: 37558496 Free PMC article.
Effectiveness and safety of morphine administration for refractory dyspnoea among hospitalised patients with advanced heart failure: the Morphine-HF study.
Hamatani Y, Iguchi M, Moriuchi K, Anchi Y, Inuzuka Y, Nishikawa R, Shimamura K, Kondo H, Mima H, Yamashita Y, Takabayashi K, Takenaka K, Korai K, Kawase Y, Murai R, Yaku H, Nagao K, Kitano M, Aono Y, Kitai T, Sato Y, Kimura T, Akao M. Hamatani Y, et al. Among authors: nishikawa r. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e1300-e1307. doi: 10.1136/spcare-2023-004247. BMJ Support Palliat Care. 2024. PMID: 37169517
614 results